Edition:
United Kingdom

Cryoport Inc (CYRX.OQ)

CYRX.OQ on NASDAQ Stock Exchange Capital Market

19.25USD
19 Jul 2019
Change (% chg)

$-0.13 (-0.67%)
Prev Close
$19.38
Open
$19.50
Day's High
$19.60
Day's Low
$19.18
Volume
74,603
Avg. Vol
92,033
52-wk High
$20.75
52-wk Low
$8.30

Latest Key Developments (Source: Significant Developments)

Cryoport Announces Pricing Of Public Offering Of Common Stock
Thursday, 20 Jun 2019 

June 19 (Reuters) - Cryoport Inc ::CRYOPORT ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING PRICED AT $17.00PER SHARE.  Full Article

Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
Thursday, 11 Apr 2019 

April 11 (Reuters) - Cryoport Inc ::CELULARITY SELECTS CRYOPORT'S TEMPERATURE CONTROLLED LOGISTICS SOLUTIONS.CRYOPORT INC - HAS BEEN SELECTED BY CELULARITY TO UTILIZE ITS COMPLETE RANGE OF TEMPERATURE-CONTROLLED SOLUTIONS.  Full Article

Cryoport Reports Q3 Net Loss Per Share Of $0.07
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Cryoport Inc ::CRYOPORT REVENUE GROWS 76% FOR THIRD QUARTER 2018; 91% GROWTH IN BIOPHARMA.Q3 REVENUE $5.3 MILLION VERSUS I/B/E/S VIEW $5.1 MILLION.QTRLY NET LOSS PER SHARE $0.07.  Full Article

Cryoport Inc - Entered Sales Agreement On Aug 24 - SEC Filing
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Cryoport Inc ::CRYOPORT INC - ON AUGUST 24, ENTERED SALES AGREEMENT, PURSUANT TO WHICH IT MAY SELL SHARES HAVING OFFERING PRICE OF UP TO $35 MILLION - SEC FILING.  Full Article

Cryoport Reports Q2 Loss Per Share Of $0.09
Thursday, 9 Aug 2018 

Aug 9 (Reuters) - Cryoport Inc ::CRYOPORT REVENUE GROWS 59 PCT FOR SECOND QUARTER 2018; 73 PCT IN BIOPHARMA.Q2 REVENUE $4.6 MILLION VERSUS I/B/E/S VIEW $4.3 MILLION.QTRLY LOSS PER SHARE $0.09.CO HAS NO DEBT, REPORTED $20.0 MILLION IN CASH AND CASH EQUIVALENTS AS OF JUNE 30.  Full Article

Cryoport Qtrly ‍​loss Per Share $0.09
Tuesday, 6 Mar 2018 

March 6 (Reuters) - Cryoport Inc ::CRYOPORT REPORTS 56% REVENUE GROWTH FOR FISCAL YEAR ENDED DECEMBER 31, 2017.Q4 REVENUE ROSE 49 PERCENT TO $3.3 MILLION.QTRLY ‍​LOSS PER SHARE $0.09.  Full Article

Cryoport revenue up 52 percent driven by BioPharma
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Cryoport Inc ::Revenue increased 52 percent to $3.0 million for three month period ended September 30, 2017​.Cryoport Inc - ‍GAAP net loss attributable to common stockholders for three month period ended September 30, 2017 was $0.08 per share​.  Full Article

Cryoport to support commercial launch of Kite Pharma's CAR-T therapy, axi-cel​
Tuesday, 5 Sep 2017 

Sept 5 (Reuters) - Cryoport Inc :Cryoport Inc - ‍Cryoport selected to support potential commercial launch of Kite Pharma's CAR-T Therapy Axicabtagene Ciloleucel​.Cryoport Inc - ‍will provide logistics support throughout United States in accordance with Kite's plans for patient adoption of axi-cel​.  Full Article

Cryoport reports Q2 loss per share $0.08
Tuesday, 8 Aug 2017 

Aug 9 (Reuters) - Cryoport Inc -:Cryoport revenue up 52% for the second quarter of 2017, driven by biopharma.Q2 revenue $2.9 million versus I/B/E/S view $2.8 million.Q2 gaap loss per share $0.08.  Full Article